Search filters

List of works by Shiro Maeyama

Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD).

scientific article

Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease

scientific article published on 3 March 2009

Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot study

scientific article

Gene expression profiling of non-alcoholic steatohepatitis using gene set enrichment analysis

article

High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH.

scientific article published on 25 July 2007

Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue

scientific article published in January 2007

Influence of inducible nitric oxide synthase polymorphisms in Japanese patients with non-alcoholic fatty liver disease

scientific article published on 13 July 2009

Nitric oxide plays a crucial role in the development/progression of nonalcoholic steatohepatitis in the choline-deficient, l-amino acid-defined diet-fed rat model

scientific article

Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH).

scientific article

Serum ferritin is a clinical biomarker in Japanese patients with nonalcoholic steatohepatitis (NASH) independent of HFE gene mutation

scientific article published on 7 March 2009

Telmisartan, an angiotensin II type 1 receptor blocker, controls progress of nonalcoholic steatohepatitis in rats

scientific article published on 05 April 2007

Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage

scientific article published on 25 May 2007